Back to Newsroom

Oncobiologics To Present At BioCentury’s NewsMakers In The Biotech Industry Conference

CRANBURY, N.J., Aug. 31, 2016 (GLOBE NEWSWIRE) — Oncobiologics, Inc. (NASDAQ:ONS), a clinical-stage biopharmaceutical company focused on identifying, developing, manufacturing and commercializing complex monoclonal antibody (mAb) biosimilar therapeutics, today announced that its Chairman, CEO and President, Pankaj Mohan, Ph.D., will present at the BioCentury’s Annual NewsMakers in the Biotech Industry Conference. The presentation will take place on Friday, September 9, 2016 at 2:30 p.m. ET in room 402/403 of the Millennium Broadway Hotel in New York City.

Click here to read the full release